CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Preferred Stock	Total Rithm Capital Stockholders’ Equity	Total Rithm Capital Stockholders’ Equity Common Stock	Total Rithm Capital Stockholders’ Equity Preferred Stock	Preferred Stock	Preferred Stock Preferred Stock	Common Stock	Common Stock Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Common Stock	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income	Noncontrolling Interests in Equity of Consolidated Subsidiaries
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2020							33,610,000
Common stock, shares outstanding beginning balance (in shares) at Dec. 31, 2020									414,744,518
Equity, beginning balance at Dec. 31, 2020	$ 5,429,684			$ 5,321,016			$ 812,992		$ 4,148		$ 5,547,108		$ (1,108,929)	$ 65,697	$ 108,668
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	(409,595)			(409,595)									(409,595)
Dividends declared on preferred stock	(66,744)			(66,744)									(66,744)
Capital distributions	(55,600)														(55,600)
Issuance stock (in shares)								18,600,000		51,903,346
Issuance of stock		$ 513,421	$ 449,489		$ 513,421	$ 449,489		$ 449,489		$ 519		$ 512,902
Purchase of non-controlling interest	(22,523)			(1,447)							(1,447)				(21,076)
Director share grants and employee non-cash stock-based compensation (in shares)									110,402
Director share grants and employee non-cash stock-based compensation	1,110			1,110					$ 2		1,108
Comprehensive income (loss):
Net income (loss)	805,582			772,226									772,226		33,356
Unrealized gain (loss) on available-for-sale securities, net	29,944			29,944										29,944
Reclassification of realized (gain) loss on available-for-sale securities, net into net income	(5,388)			(5,388)										(5,388)
Cumulative translation adjustment	0
Total comprehensive income (loss)	830,138			796,782											33,356
Preferred stock, shares outstanding, ending balance (in shares) at Dec. 31, 2021							52,210,000
Common stock, shares outstanding ending balance (in shares) at Dec. 31, 2021									466,758,266
Equity, ending balance at Dec. 31, 2021	6,669,380			6,604,032			$ 1,262,481		$ 4,669		6,059,671		(813,042)	90,253	65,348
Comprehensive income (loss):
Net income (loss)	$ 689,931
Preferred stock, shares outstanding, ending balance (in shares) at Mar. 31, 2022	52,038,000
Common stock, shares outstanding ending balance (in shares) at Mar. 31, 2022	466,786,526
Equity, ending balance at Mar. 31, 2022	$ 7,184,712
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2021							52,210,000
Common stock, shares outstanding beginning balance (in shares) at Dec. 31, 2021									466,758,266
Equity, beginning balance at Dec. 31, 2021	6,669,380			6,604,032			$ 1,262,481		$ 4,669		6,059,671		(813,042)	90,253	65,348
Comprehensive income (loss):
Net income (loss)	$ 723,262
Preferred stock, shares outstanding, ending balance (in shares) at Jun. 30, 2022	52,038,000
Common stock, shares outstanding ending balance (in shares) at Jun. 30, 2022	466,856,753
Equity, ending balance at Jun. 30, 2022	$ 7,062,998
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2021							52,210,000
Common stock, shares outstanding beginning balance (in shares) at Dec. 31, 2021									466,758,266
Equity, beginning balance at Dec. 31, 2021	6,669,380			6,604,032			$ 1,262,481		$ 4,669		6,059,671		(813,042)	90,253	65,348
Comprehensive income (loss):
Net income (loss)	$ 877,452
Preferred stock, shares outstanding, ending balance (in shares) at Sep. 30, 2022	52,038,000
Common stock, shares outstanding ending balance (in shares) at Sep. 30, 2022	473,715,100
Equity, ending balance at Sep. 30, 2022	$ 7,061,626
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2021							52,210,000
Common stock, shares outstanding beginning balance (in shares) at Dec. 31, 2021									466,758,266
Equity, beginning balance at Dec. 31, 2021	6,669,380			6,604,032			$ 1,262,481		$ 4,669		6,059,671		(813,042)	90,253	65,348
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	(470,413)			(470,413)									(470,413)
Dividends declared on preferred stock	(89,726)			(89,726)									(89,726)
Capital distributions	(27,047)														(27,047)
Repurchases of preferred stock (in shares)							(245,878)
Repurchases of preferred stock	(5,227)			(5,227)			$ (5,227)
Cashless exercise of 2020 Warrants (in shares)									6,858,347
Cashless exercise of 2020 Warrants	0								$ 69		(69)
Director share grants and employee non-cash stock-based compensation (in shares)									98,487
Director share grants and employee non-cash stock-based compensation	2,418			2,418					$ 1		2,417
Comprehensive income (loss):
Net income (loss)	983,285			954,519									954,519		28,766
Unrealized gain (loss) on available-for-sale securities, net	(52,602)			(52,602)										(52,602)
Reclassification of realized (gain) loss on available-for-sale securities, net into net income	0
Cumulative translation adjustment	0
Total comprehensive income (loss)	$ 930,683			901,917											28,766
Preferred stock, shares outstanding, ending balance (in shares) at Dec. 31, 2022	51,964,122						51,964,122
Common stock, shares outstanding ending balance (in shares) at Dec. 31, 2022	473,715,100								473,715,100
Equity, ending balance at Dec. 31, 2022	$ 7,010,068			6,943,001			$ 1,257,254		$ 4,739		6,062,019		(418,662)	37,651	67,067
Preferred stock, shares outstanding, beginning balance (in shares) at Mar. 31, 2022	52,038,000
Common stock, shares outstanding beginning balance (in shares) at Mar. 31, 2022	466,786,526
Equity, beginning balance at Mar. 31, 2022	$ 7,184,712
Comprehensive income (loss):
Net income (loss)	$ 33,331
Preferred stock, shares outstanding, ending balance (in shares) at Jun. 30, 2022	52,038,000
Common stock, shares outstanding ending balance (in shares) at Jun. 30, 2022	466,856,753
Equity, ending balance at Jun. 30, 2022	$ 7,062,998
Comprehensive income (loss):
Net income (loss)	$ 154,190
Preferred stock, shares outstanding, ending balance (in shares) at Sep. 30, 2022	52,038,000
Common stock, shares outstanding ending balance (in shares) at Sep. 30, 2022	473,715,100
Equity, ending balance at Sep. 30, 2022	$ 7,061,626
Comprehensive income (loss):
Net income (loss)	$ 105,833
Preferred stock, shares outstanding, ending balance (in shares) at Dec. 31, 2022	51,964,122						51,964,122
Common stock, shares outstanding ending balance (in shares) at Dec. 31, 2022	473,715,100								473,715,100
Equity, ending balance at Dec. 31, 2022	$ 7,010,068			6,943,001			$ 1,257,254		$ 4,739		6,062,019		(418,662)	37,651	67,067
Comprehensive income (loss):
Net income (loss)	$ 89,949
Preferred stock, shares outstanding, ending balance (in shares) at Mar. 31, 2023	51,964,122
Common stock, shares outstanding ending balance (in shares) at Mar. 31, 2023	483,017,747
Equity, ending balance at Mar. 31, 2023	$ 6,954,543
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2022	51,964,122						51,964,122
Common stock, shares outstanding beginning balance (in shares) at Dec. 31, 2022	473,715,100								473,715,100
Equity, beginning balance at Dec. 31, 2022	$ 7,010,068			6,943,001			$ 1,257,254		$ 4,739		6,062,019		(418,662)	37,651	67,067
Comprehensive income (loss):
Net income (loss)	$ 476,634
Preferred stock, shares outstanding, ending balance (in shares) at Jun. 30, 2023	51,964,122
Common stock, shares outstanding ending balance (in shares) at Jun. 30, 2023	483,320,606
Equity, ending balance at Jun. 30, 2023	$ 7,194,684
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2022	51,964,122						51,964,122
Common stock, shares outstanding beginning balance (in shares) at Dec. 31, 2022	473,715,100								473,715,100
Equity, beginning balance at Dec. 31, 2022	$ 7,010,068			6,943,001			$ 1,257,254		$ 4,739		6,062,019		(418,662)	37,651	67,067
Comprehensive income (loss):
Net income (loss)	$ 697,825
Preferred stock, shares outstanding, ending balance (in shares) at Sep. 30, 2023	51,964,122
Common stock, shares outstanding ending balance (in shares) at Sep. 30, 2023	483,214,061
Equity, ending balance at Sep. 30, 2023	$ 7,267,963
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2022	51,964,122						51,964,122
Common stock, shares outstanding beginning balance (in shares) at Dec. 31, 2022	473,715,100								473,715,100
Equity, beginning balance at Dec. 31, 2022	$ 7,010,068			6,943,001			$ 1,257,254		$ 4,739		6,062,019		(418,662)	37,651	67,067
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	(483,192)			(483,192)									(483,192)
Dividends declared on preferred stock	(89,579)			(89,579)									(89,579)
Capital contributions	4,733														4,733
Capital distributions	(21,994)														(21,994)
Cashless exercise of 2020 Warrants (in shares)									9,287,347
Cashless exercise of 2020 Warrants	0								$ 93		(93)
Purchase of non-controlling interest	35,873			0							0				35,873
Director share grants and employee non-cash stock-based compensation (in shares)									223,792
Director share grants and employee non-cash stock-based compensation	8,432			8,432					$ 1		12,396		(3,965)
Comprehensive income (loss):
Net income (loss)	630,674			622,257									622,257		8,417
Unrealized gain (loss) on available-for-sale securities, net	5,437			5,437										5,437
Reclassification of realized (gain) loss on available-for-sale securities, net into net income	0
Cumulative translation adjustment	586			586										586
Total comprehensive income (loss)	$ 636,697			628,280											8,417
Preferred stock, shares outstanding, ending balance (in shares) at Dec. 31, 2023	51,964,122						51,964,122
Common stock, shares outstanding ending balance (in shares) at Dec. 31, 2023	483,226,239								483,226,239
Equity, ending balance at Dec. 31, 2023	$ 7,101,038			7,006,942			$ 1,257,254		$ 4,833		6,074,322		(373,141)	43,674	94,096
Preferred stock, shares outstanding, beginning balance (in shares) at Mar. 31, 2023	51,964,122
Common stock, shares outstanding beginning balance (in shares) at Mar. 31, 2023	483,017,747
Equity, beginning balance at Mar. 31, 2023	$ 6,954,543
Comprehensive income (loss):
Net income (loss)	$ 386,685
Preferred stock, shares outstanding, ending balance (in shares) at Jun. 30, 2023	51,964,122
Common stock, shares outstanding ending balance (in shares) at Jun. 30, 2023	483,320,606
Equity, ending balance at Jun. 30, 2023	$ 7,194,684
Comprehensive income (loss):
Net income (loss)	$ 221,191
Preferred stock, shares outstanding, ending balance (in shares) at Sep. 30, 2023	51,964,122
Common stock, shares outstanding ending balance (in shares) at Sep. 30, 2023	483,214,061
Equity, ending balance at Sep. 30, 2023	$ 7,267,963
Comprehensive income (loss):
Net income (loss)	$ (67,151)
Preferred stock, shares outstanding, ending balance (in shares) at Dec. 31, 2023	51,964,122						51,964,122
Common stock, shares outstanding ending balance (in shares) at Dec. 31, 2023	483,226,239								483,226,239
Equity, ending balance at Dec. 31, 2023	$ 7,101,038			$ 7,006,942			$ 1,257,254		$ 4,833		$ 6,074,322		$ (373,141)	$ 43,674	$ 94,096